These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1441532)
1. [Burgdorf's reaction (painful acral erythema) in patients with acute lymphoblastic leukemia following medium-dose methotrexate therapy]. Wysocki M; Nowaczyk-Michalak A; Pilecki O; Kurylak A; Balcar-Boroń A; Trybuś L Wiad Lek; 1992 Jun; 45(11-12):462-4. PubMed ID: 1441532 [TBL] [Abstract][Full Text] [Related]
2. Acral erythema with oral methotrexate in a child. Varela CR; McNamara J; Antaya RJ Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806 [TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema. Tezer H; Kuskonmaz B; Kara A; Devrim I; Tuncer M; Cengiz AB; Yetgin S; Seçmeer G J Pediatr Hematol Oncol; 2008 May; 30(5):391-3. PubMed ID: 18458576 [TBL] [Abstract][Full Text] [Related]
4. Acral erythema with bullous formation: a side effect of chemotherapy in a child with acute lymphoblastic leukemia. Aytaç S; Gümrük F; Cetin M; Tuncer M; Yetgin S Turk J Pediatr; 2010; 52(2):211-4. PubMed ID: 20560263 [TBL] [Abstract][Full Text] [Related]
5. Acral erythema in children receiving high-dose methotrexate. Millot F; Auriol F; Brecheteau P; Guilhot F Pediatr Dermatol; 1999; 16(5):398-400. PubMed ID: 10571844 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced painful acral erythema in childhood: Burgdorf's reaction. Burke MC; Bernhard JD; Michelson AD Am J Pediatr Hematol Oncol; 1989; 11(1):44-5. PubMed ID: 2712242 [TBL] [Abstract][Full Text] [Related]
8. Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma. Postovsky S; Ben Arush MW Pediatr Hematol Oncol; 2005 Mar; 22(2):167-73. PubMed ID: 15805003 [TBL] [Abstract][Full Text] [Related]
9. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038 [TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study. Lange BJ; Blatt J; Sather HN; Meadows AT Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced acral erythema in a pediatric patient with acute monoblastic leukemia. Demircioğlu F; Oren H; Yilmaz S; Arslansoyu S; Eren S; Irken G Pediatr Hematol Oncol; 2008; 25(3):211-5. PubMed ID: 18432504 [TBL] [Abstract][Full Text] [Related]
12. [High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children]. Makhonova LA; Maiakova SA; Kiselev AV; Gordina GA; Balakirev SA; Gavrilova IE; Moiseenko EI; Morozova OV Vopr Onkol; 1990; 36(10):1196-200. PubMed ID: 2251813 [TBL] [Abstract][Full Text] [Related]
13. [Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug]. Wysocki M; Balcar-Boroń A; Krzyzanowski M; Szadujkis-Szadurski L; Ozyński T; Nowaczyk-Michalak A Acta Haematol Pol; 1992; 23(3):185-90. PubMed ID: 1492543 [TBL] [Abstract][Full Text] [Related]
14. [Assessment of elimination and tolerance of high dose of methotrexate (3 g/m2) in children with standard-risk acute lymphoblastic leukemia]. Cwliklińska M; Balwierz W; Nowak J; Stanuch H Przegl Lek; 2006; 63(1):15-20. PubMed ID: 16892893 [TBL] [Abstract][Full Text] [Related]
15. [Treatment results in children with the standard risk acute lymphoblastic leukemia treated with high dose of methotrexate (5.0 g/m2). 11 years of the Polish Pediatric Leukemia/Lymphoma Study Group experience]. Derwich K; Wachowiaki J; Kaczmarek-Kanoldi M; Balcerska A; Balwierz W; Chybicka A; Kowalczyk JR; Matysiak M; Jackowska T; Sońta-Jakimczyk D; Wysocki M; Chełmecka-Hanuszewicz L; Cwiklińska M; Kołtan A; Malinowska I; Odój T; Płoszyńska A; Steczowicz M; Wojciechowska V; Wójtowicz A; Przegl Lek; 2006; 63(1):7-10. PubMed ID: 16892891 [TBL] [Abstract][Full Text] [Related]
17. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia]. Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849 [TBL] [Abstract][Full Text] [Related]
18. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Refsum H; Wesenberg F; Ueland PM Cancer Res; 1991 Feb; 51(3):828-35. PubMed ID: 1988122 [TBL] [Abstract][Full Text] [Related]
19. High-dose Methotrexate-induced Acral Erythema in Two Pediatric Patients With Acute Lymphoblastic Leukemia: A 17 Pediatric Case Series of Methotrexate-induced Acral Erythema. Noguchi K; Nishimura R; Ikawa Y; Mase S; Fujiki T; Kuroda R; Araki R; Maeba H; Yachie A; Wada T J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1259-e1261. PubMed ID: 34486565 [No Abstract] [Full Text] [Related]
20. Comparison of long-term neurocognitive outcomes in young children with acute lymphatic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. Cohen IJ J Clin Oncol; 2007 Feb; 25(6):734-5; author reply 735. PubMed ID: 17308283 [No Abstract] [Full Text] [Related] [Next] [New Search]